In this regard, it is interesting to note that shPLCε suppressed JNK activity by decreasing the expression of MEK4 in prostate cancer, thereby reducing the expression of twist, a transcription factor that strongly induces epithelial–mesenchymal transition [40]. Here, MAP2K4 is linked to prostate carcinoma.